Recent News

521 News Items found
Human metastatic melanoma cells in a lymph node. ENPP1, a protein involved in immune evasion, is shown in green.
The research identifies a protein called ENPP1 as a potential drug target in the treatment of advanced cancers with chromosome instability.
Dana Pe'er, Chair of the Computational and Systems Biology Program at the Sloan Kettering Institute
Take a look back at some of the biggest cancer science stories from this past year.
Physician-scientist Charles Rudin
In the Clinic
Researchers discover that a subset of lung adenocarcinomas are aggressive because of mutations that allow them to block ferroptosis, a type of cell death.
Structure of an intermediate during the homologous recombination reaction.
The high-resolution views provided by cryo-electron microscopy are helping scientists learn how proteins and DNA collaborate to repair broken DNA.
Nadeem Riaz (left) and Jorge Reis-Filho (right)
Human data and results from mouse experiments suggest that people with BRCA2 mutations may respond well to immunotherapy drugs.
Systems biologist Joao Xavier in his lab
Finding
MSK researchers have shown for the first time that the concentration of different types of immune cells in the blood changes in relation to the presence of different bacterial strains in the gut.
SKI cell biologists Junmei Yi and Xuejun Jiang
In the Lab
Cancers with certain mutations are vulnerable to ferroptosis, a form of iron-dependent cell death.
Postdoctoral fellows Linde Miles and Robert Bowman in the lab.
In the Lab
New research looks at how a series of mutations in normal blood cells can lead to them becoming cancerous and how these mutations accumulate as cancer progresses.
An illustration of a reel of film
In the Lab
Grab your popcorn and pull up a chair for these video shorts of cell signaling in early mouse development.
Finding
New research focuses on clonal hematopoiesis, an age-related blood condition that increases the risk of blood cancer.